These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia. Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353 [TBL] [Abstract][Full Text] [Related]
10. Autophagy in chronic myeloid leukaemia: stem cell survival and implication in therapy. Helgason GV; Mukhopadhyay A; Karvela M; Salomoni P; Calabretta B; Holyoake TL Curr Cancer Drug Targets; 2013 Sep; 13(7):724-34. PubMed ID: 23941517 [TBL] [Abstract][Full Text] [Related]
11. Targeting ULK1 in cancer stem cells: insight from chronic myeloid leukemia. Ianniciello A; Helgason GV Autophagy; 2022 Jul; 18(7):1734-1736. PubMed ID: 35227175 [TBL] [Abstract][Full Text] [Related]
15. Comparative effect of imatinib and ponatinib on autophagy and miRNome in chronic myeloid leukemia. Kayabasi C; Okcanoglu TB; Yelken BO; Asik A; Susluer SY; Avci CB; Saydam G; Gunduz C Gene; 2017 Dec; 637():173-180. PubMed ID: 28942039 [TBL] [Abstract][Full Text] [Related]
16. Leukemia Stem Cells in Chronic Myeloid Leukemia. Shan Y; DeSouza N; Qiu Q; Li S Adv Exp Med Biol; 2019; 1143():191-215. PubMed ID: 31338821 [TBL] [Abstract][Full Text] [Related]
17. The role of Fas-associated phosphatase 1 in leukemia stem cell persistence during tyrosine kinase inhibitor treatment of chronic myeloid leukemia. Huang W; Luan CH; Hjort EE; Bei L; Mishra R; Sakamoto KM; Platanias LC; Eklund EA Leukemia; 2016 Jul; 30(7):1502-9. PubMed ID: 26984787 [TBL] [Abstract][Full Text] [Related]
18. Metabolic alterations mediated by STAT3 promotes drug persistence in CML. Patel SB; Nemkov T; Stefanoni D; Benavides GA; Bassal MA; Crown BL; Matkins VR; Camacho V; Kuznetsova V; Hoang AT; Tenen DE; Wolock SL; Park J; Ying L; Yue Z; Chen JY; Yang H; Tenen DG; Ferrell PB; Lu R; Darley-Usmar V; D'Alessandro A; Bhatia R; Welner RS Leukemia; 2021 Dec; 35(12):3371-3382. PubMed ID: 34120146 [TBL] [Abstract][Full Text] [Related]
19. Targeting of the BLT2 in chronic myeloid leukemia inhibits leukemia stem/progenitor cell function. Xiao M; Ai H; Li T; Rajoria P; Shahu P; Li X Biochem Biophys Res Commun; 2016 Apr; 472(4):610-6. PubMed ID: 26966074 [TBL] [Abstract][Full Text] [Related]
20. Targeted therapies and autophagy: new insights from chronic myeloid leukemia. Salomoni P; Calabretta B Autophagy; 2009 Oct; 5(7):1050-1. PubMed ID: 19713759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]